Portal de Periódicos da CAPES

Strategies to manage hepatitis C virus infection disease burden – volume 3

2015; Wiley; Volume: 22; Issue: S4 Linguagem: Inglês

10.1111/jvh.12474

1365-2893

Faleh Z. Al-Faleh, N. Nugrahini, Mojca Matičič, Ieva Tolmane, Moza A Alzaabi, Behzad Hajarizadeh, Jonas Valantinas, Do Young Kim, B Hunyady, Faisal Abaalkhail, Zaigham Abbas, Ahmed Ms Abdou, A. Abourached, F. Al Braiki, Farida Al Hosani, K. Al Jaberi, Maryam Al Khatry, Mariam Al Mulla, Huda Al Quraishi, A. Al Rifai, Y. Al Serkal, Altaf Alam, Hamad I. Al‐Ashgar, Seyed Moayed Alavian, Sameer Alawadhi, L. Al‐Dabal, Pauls Aldiņš, Abdullah Alghamdi, Raafat F. Alhakeem, Abdulrahman Aljumah, A. Almessabi, Adel Alqutub, Khalid Alswat, Ibrahim Altraif, N. Andrea, Abdullah M. Assiri, Mohammed A. Babatin, Agha Wajdan Baqir, Maha T Barakat, Ottar M. Bergmann, Abdul Rahman Bizri, Asad Chaudhry, Moon Seok Choi, T. Diab, Samsuridjal Djauzi, Ehsan Hassan, Salem Khoury, Chris Estes, Samir M. Fakhry, Javed Iqbal Farooqi, H. Fridjonsdottir, Rino Alvani Gani, Aamir Khan, Liana Gheorghe, Adrian Goldiș, Magnús Gottfreðsson, S. Gregorčič, J. Gunter, Saeed Hamid, Kwang–Hyub Han, Irsan Hasan, A. Hashim, Gábor Horváth, Rola Husni, Wasim Jafri, Agita Jēruma, Jón G. Jónasson, B. Karlsdottir, Y. S. Kim, Zaher Koutoubi, Laurentius A. Lesmana, Valentina Liakina, Young‐Suk Lim, Arthur Löve, Matti Maimets, Michael Makara, Reza Malekzadeh, Muhammad Sadik Memon, Shahin Merat, Jacques Mokhbat, Fadi H. Mourad, David Handojo Muljono, Arif Nawaz, Sigurður Ólafsson, S. Priohutomo, H Qureshi, P. Rassam, Homie Razavi, Devin Razavi‐Shearer, Kathryn Razavi‐Shearer, Baiba Rozentāle, M. Sadik, Khwaja Mir Islam Saeed, Amjad Salamat, R. Salupere, Faisal M. Sanai, Andri Sanityoso Sulaiman, Raymond Sayegh, Jonathan Schmelzer, Alaa Sharara, Anjali Sibley, M. Siddiq, A. M. Siddiqui, G. Sigmundsdóttir, Bryndís Sigurðardóttir, Danutė Speičienė, Andri Sanityoso Sulaiman, M. A. Sultan, M. Taha, Junko Tanaka, H. Tarifi, Ghias Un Nabi Tayyab, M. Ud din, Muhammad Umar, J. Videčnik‐Zorman, César Yaghi, Evy Yunihastuti, Muhammed Aasim Yusuf, Bader Faiyaz Zuberi, Sarah Blach,

Hepatitis B Virus Studies

Summary The hepatitis C virus ( HCV ) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: increased treatment efficacy while holding the annual number of treated patients constant and increased treatment efficacy and an increased annual number of treated patients. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. A 90% reduction in total HCV infections within 15 years is feasible in most countries studied, but it required a coordinated effort to introduce harm reduction programmes to reduce new infections, screening to identify those already infected and treatment with high cure rate therapies. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. Among European countries, the majority of patients were born between 1940 and 1985. A wider range of birth cohorts was seen in the Middle East and Asia (between 1925 and 1995).